Semax (25mg)

$53.00

Semax (25mg) is offered by Biotech Peptides for laboratory and analytical research. Semax is a synthetic heptapeptide analogue of ACTH(4-10) studied in relation to neurotrophin gene expression and ischemic injury models. 1041

  • Product: Semax

  • Full name: ACTH(4-7)-Pro-Gly-Pro

  • Listed quantity: 25 mg

  • Reference molecular formula: C₃₉H₅₄N₁₀O₁₀S

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

Out of stock

SKU: Semax-25mg Category:
Description

Semax (25mg) for Laboratory Research

Semax (25mg) is offered by Biotech Peptides for laboratories investigating neurotrophin gene expression, ischemic injury models, and neuroprotective peptide research. Semax is a synthetic heptapeptide consisting of the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro, derived from the N-terminal fragment of adrenocorticotropic hormone. 1041

For laboratories looking to buy Semax, this listing identifies a 25 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Semax Product Information

Property Listing information
Product name Semax
Full name ACTH(4-7)-Pro-Gly-Pro
Listed quantity 25 mg
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 25 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.

Semax Reference Molecular Characteristics

The following characteristics describe the Semax reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide length 7 residues
Reference sequence Met-Glu-His-Phe-Pro-Gly-Pro
Molecular formula C₃₉H₅₄N₁₀O₁₀S
Approximate molecular weight 854.99 g/mol
Chemical class Synthetic heptapeptide ACTH analogue

The sequence and molecular formula are documented in the Semax research summary and in the Semax research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1041

Semax and Neurotrophin Gene Expression

A study of Semax and neurotrophin gene expression in rat brain reported that intranasal application of Semax increased the expression of both neurotrophin genes in rat hippocampus. The investigators also reported that BDNF gene expression increased in the brainstem and cerebellum, while NGF gene expression decreased in the frontal cortex. 1046

A separate study of Semax and BDNF gene expression in rat hippocampus, frontal cortex, and retina reported that expression of both neurotrophin genes was decreased in rat hippocampus and retina 20 minutes after Semax administration, and increased in the frontal cortex. 1045

Read the primary neurotrophin gene-expression study for the experimental design and limitations.

Semax and Ischemic Injury Research

A study of Semax and gene expression in rat brain focal ischemia reported that Semax influenced the expression of genes that promote the formation and functioning of the vascular system. The investigators reported that Semax enhanced the transcription of BDNF, TrkC, and TrkA 3 hours after occlusion, and NGF 24 hours after occlusion. 1039

A separate study of Semax and BDNF gene expression in rat hippocampus, frontal cortex, and retina reported that Semax administration resulted in rapid, long-term, and specific activation of BDNF and NGF expression changes in different rat brain departments. 1042

These findings apply to specific animal models and exposure protocols. They do not establish that a commercial Semax batch improves cognitive function, prevents stroke, or produces a cosmetic effect in humans. 1039

Research Limitations

Published Semax research examines receptor signaling, cell-based assays, and animal models. It does not establish that Semax treats stroke, cognitive impairment, anxiety, depression, or any other condition. 1039

Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.

Documentation and Batch Verification

Before selecting Semax (25mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.

For inquiries, provide “Semax (25mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About Semax (25mg)

What is Semax?

Semax is a synthetic heptapeptide consisting of the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro, derived from the N-terminal fragment of adrenocorticotropic hormone. 1041

Is Semax the same as ACTH?

No. Semax is a synthetic heptapeptide analogue of ACTH(4-10). It is not the same molecule as ACTH. 1041

Does Semax increase BDNF?

A study of Semax and neurotrophin gene expression in rat brain reported that intranasal application of Semax increased the expression of both neurotrophin genes in rat hippocampus. This does not establish that a commercial Semax batch increases BDNF in humans. 1046

What does the 25mg designation mean?

It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

Semax (25mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery